292 related articles for article (PubMed ID: 24043631)
1. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
[TBL] [Abstract][Full Text] [Related]
2. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
[TBL] [Abstract][Full Text] [Related]
3. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
Kharbanda A; Rajabi H; Jin C; Raina D; Kufe D
Mol Cancer Res; 2013 Jul; 11(7):714-23. PubMed ID: 23538857
[TBL] [Abstract][Full Text] [Related]
5. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY
J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215
[TBL] [Abstract][Full Text] [Related]
6. Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta.
Elizondo G; Corchero J; Sterneck E; Gonzalez FJ
J Biol Chem; 2000 Dec; 275(50):39747-53. PubMed ID: 10995752
[TBL] [Abstract][Full Text] [Related]
7. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
8. EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma.
Nachiyappan A; Soon JLJ; Lim HJ; Lee VK; Taneja R
J Pathol; 2022 Mar; 256(3):349-362. PubMed ID: 34897678
[TBL] [Abstract][Full Text] [Related]
9. Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Wang R; Yang L; Li S; Ye D; Yang L; Liu Q; Zhao Z; Cai Q; Tan J; Li X
Med Sci Monit; 2018 Jan; 24():412-420. PubMed ID: 29353288
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
[TBL] [Abstract][Full Text] [Related]
11. Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells.
Jin C; Rajabi H; Pitroda S; Li A; Kharbanda A; Weichselbaum R; Kufe D
PLoS One; 2012; 7(7):e39432. PubMed ID: 22792175
[TBL] [Abstract][Full Text] [Related]
12. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.
Kufe DW
Oncogene; 2013 Feb; 32(9):1073-81. PubMed ID: 22580612
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
[TBL] [Abstract][Full Text] [Related]
14. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
15. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract][Full Text] [Related]
16. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
[TBL] [Abstract][Full Text] [Related]
17. Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1.
Makia NL; Amunom I; Falkner KC; Conklin DJ; Surapureddi S; Goldstein JA; Prough RA
Mol Pharmacol; 2012 Oct; 82(4):601-13. PubMed ID: 22740640
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction.
Elizondo G; Medina-Díaz IM; Cruz R; Gonzalez FJ; Vega L
Biochem Pharmacol; 2009 Jan; 77(2):248-57. PubMed ID: 18992716
[TBL] [Abstract][Full Text] [Related]
19. MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.
Hiraki M; Suzuki Y; Alam M; Hinohara K; Hasegawa M; Jin C; Kharbanda S; Kufe D
Sci Rep; 2016 May; 6():26643. PubMed ID: 27217294
[TBL] [Abstract][Full Text] [Related]
20. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
